News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
103,423 Results
Type
Article (6403)
Company Profile (20)
Press Release (97000)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (31080)
Career Advice (201)
Deals (4816)
Drug Delivery (5)
Drug Development (9158)
Employer Resources (13)
FDA (2889)
Job Trends (2961)
News (50225)
Policy (5493)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (3)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
Academia (669)
Academic (1)
Allergies (14)
Alliances (10039)
ALS (13)
Alzheimer's disease (186)
Antibody-drug conjugate (ADC) (13)
Approvals (2927)
Artificial intelligence (33)
Automation (9)
Bankruptcy (30)
Best Places to Work (2299)
BIOSECURE Act (1)
Biosimilars (5)
Biotechnology (14)
Bladder cancer (10)
Brain cancer (4)
Breast cancer (47)
Cancer (352)
Cardiovascular disease (20)
Career advice (185)
Career pathing (1)
CAR-T (21)
Cell therapy (48)
Cervical cancer (9)
Clinical research (7085)
Collaboration (152)
Compensation (2)
Complete response letters (3)
COVID-19 (565)
CRISPR (5)
C-suite (23)
Cystic fibrosis (7)
Data (290)
Depression (1)
Diabetes (23)
Diagnostics (3161)
Digital health (1)
Diversity, equity & inclusion (2)
Drug discovery (21)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (8)
Earnings (8970)
Editorial (1)
Employer branding (3)
Employer resources (11)
Events (10440)
Executive appointments (101)
FDA (3036)
Featured Employer (4)
Frontotemporal dementia (1)
Funding (78)
Gene editing (8)
Generative AI (3)
Gene therapy (33)
GLP-1 (104)
Government (900)
Grass and pollen (3)
Guidances (5)
Healthcare (2267)
Immunology and inflammation (3)
Indications (4)
Infectious disease (597)
Inflammatory bowel disease (7)
Influenza (16)
Intellectual property (11)
Interviews (24)
IPO (1454)
Job creations (774)
Job search strategy (176)
Kidney cancer (1)
Labor market (2)
Layoffs (31)
Leadership (1)
Legal (1116)
Liver cancer (8)
Lung cancer (62)
Lymphoma (26)
Machine learning (1)
Management (4)
Manufacturing (49)
MASH (3)
Medical device (1398)
Medtech (1398)
Mergers & acquisitions (3432)
Metabolic disorders (44)
Multiple sclerosis (5)
NASH (1)
Neurodegenerative disease (12)
Neuropsychiatric disorders (1)
Neuroscience (229)
NextGen: Class of 2025 (800)
Non-profit (581)
Northern California (245)
Now hiring (11)
Obesity (19)
Opinion (14)
Ovarian cancer (5)
Pain (5)
Pancreatic cancer (8)
Parkinson's disease (14)
Partnered (4)
Patents (19)
Patient recruitment (5)
Peanut (9)
People (9386)
Pharmaceutical (6)
Phase I (2103)
Phase II (2763)
Phase III (2711)
Pipeline (139)
Policy (4)
Postmarket research (394)
Preclinical (1233)
Press Release (19)
Prostate cancer (21)
Psychedelics (2)
Radiopharmaceuticals (29)
Rare diseases (31)
Real estate (1972)
Recruiting (4)
Regulatory (3777)
Reports (7)
Research institute (634)
Resumes & cover letters (19)
RSV (5)
Series A (10)
Series B (8)
Sickle cell disease (5)
Southern California (254)
Spinal muscular atrophy (34)
Sponsored (6)
Startups (609)
State (1)
Stomach cancer (2)
Supply chain (10)
Tariffs (1)
The Weekly (1)
United States (2683)
Vaccines (54)
Venture capitalists (1)
Weight loss (11)
Women's health (3)
Date
Today (9)
Last 7 days (45)
Last 30 days (269)
Last 365 days (4068)
2025 (1048)
2024 (4456)
2023 (5319)
2022 (8657)
2021 (9021)
2020 (8817)
2019 (6164)
2018 (4778)
2017 (5212)
2016 (5324)
2015 (5893)
2014 (4751)
2013 (4206)
2012 (4430)
2011 (4515)
2010 (4025)
Location
Africa (125)
Alabama (10)
Alaska (1)
Arizona (33)
Arkansas (2)
Asia (6419)
Australia (1070)
California (619)
Canada (248)
China (28)
Colorado (34)
Connecticut (47)
Delaware (25)
Europe (14130)
Florida (86)
Georgia (10)
Idaho (5)
Illinois (40)
India (3)
Indiana (37)
Iowa (2)
Japan (18)
Kansas (21)
Kentucky (4)
Louisiana (1)
Maine (24)
Maryland (102)
Massachusetts (391)
Michigan (59)
Minnesota (32)
Missouri (33)
Montana (9)
Nebraska (3)
Nevada (3)
New Hampshire (7)
New Jersey (271)
New Mexico (8)
New York (204)
North Carolina (143)
North Dakota (1)
Northern California (245)
Ohio (37)
Oklahoma (3)
Oregon (3)
Pennsylvania (110)
Rhode Island (10)
South America (176)
South Carolina (3)
Southern California (254)
Tennessee (17)
Texas (158)
Utah (58)
Virginia (11)
Washington D.C. (4)
Washington State (81)
Wisconsin (9)
103,423 Results for "fugacil nanomedicine laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Esphera SynBio closes seed financing round to develop nanomedicine vaccines for cancer and infectious disease
January 7, 2025
·
2 min read
Press Releases
Ardena’s New State-of-the-Art Nanomedicine Facility Secures Full GMP Approval for Manufacturing
November 19, 2024
·
3 min read
Business
Lilly, UCB-Backed ViaNautis Scores $25M for Genetic Nanomedicines
The UK-based nanomedicine biotech, previously known as SomaServe, has closed its Series A with some significant biopharma names attached.
November 13, 2023
·
2 min read
·
Tyler Patchen
ViaNautis Bio announces $25 million Series A financing to drive the next generation of genetic nanomedicines
ViaNautis Bio, a groundbreaking nanomedicine company at the forefront of genetic therapies, is excited to announce the successful completion of its Series A funding round, raising $25 million.
November 13, 2023
·
7 min read
Press Releases
U.S. Nanomedicine Market Size to Hit USD 279.69 Billion by 2033
June 19, 2024
·
11 min read
Press Releases
Sable Therapeutics Announces Exclusive Worldwide Licensing Agreement with Columbia University to Develop Novel Polycation Nanomedicines for the Treatment of Obesity
August 12, 2024
·
2 min read
Press Releases
Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
April 15, 2025
·
1 min read
Press Releases
Kraig Biocraft Laboratories Announces the Launch of Advanced Gene-Splicing Program and New Transgenics
April 16, 2025
·
3 min read
Press Releases
Charles River Laboratories to Present at Barclays Global Healthcare Conference
March 11, 2025
·
1 min read
Press Releases
GenomOncology Partners with Chronetyx Laboratories to Accelerate Cancer Care Through Comprehensive Genomic Profiling
March 31, 2025
·
3 min read
1 of 10,343
Next
